ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)
37.08
+0.68 (1.87%)
Jul 21, 2026, 3:06 PM CST
ApicHope Pharmaceutical Group Company Description
ApicHope Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China.
The company offers pediatric medicines; chronic disease drugs; active pharmaceutical ingredients and formulations; and specialty traditional Chinese medicines.
It is also involved in scientific research and technical services; wholesale and retail trade; information technology; and technology promotion and application services.
The company was formerly known as ApicHope Pharmaceutical Co., Ltd and changed its name to ApicHope Pharmaceutical Group Co., Ltd. in December 2024.
ApicHope Pharmaceutical Group Co., Ltd. was founded in 2002 and is headquartered in Guangzhou, China.
ApicHope Pharmaceutical Group Co., Ltd.
| Country | China |
| Founded | 2002 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,294 |
| CEO | Hanxiong Li |
Contact Details
Address: Yunrun Building Guangzhou, 510320 China | |
| Phone | 86 20 2887 7666 |
| Website | apichope.com |
Stock Details
| Ticker Symbol | 300723 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000035J7 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Hanxiong Li | Chairman of the Board of Directors and GM |
| Huixing Zhang | Accounting Supervisor and Chief Financial Officer |
| Dongling Yang | Deputy GM and Non-Independent Director |
| Mingyuan Zhang | Deputy GM and Secretary of Board |